论文部分内容阅读
目的 :探讨米索前列醇、宫缩素联合运用在预防产妇产后出血的临床疗效;方法 :将我院102例临产产妇随机分为对照组和观察组,前者单纯运用宫缩素,后者在对照组基础上联合米索前列醇,比较两组止血效果;结果:观察组第三产程时间(6.8±3.1)min短于对照组(7.9±3.6)min,产后2h出血量(178.35±21.12)ml、24h内出血量(267.34±41.12)ml明显低于对照组(254.37±28.33)ml、(401.32±51.27)ml,且P<0.05。讨论:联合运用米索前列醇、宫缩素预防产妇产后出血效果显著,值得推广和运用。
Objective: To investigate the clinical efficacy of misoprostol combined with oxytocin in the prevention of postpartum hemorrhage.Methods: 102 cases of labor in our hospital were randomly divided into control group and observation group, (6.8 ± 3.1) min in the observation group was shorter than that in the control group (7.9 ± 3.6) min, and the amount of bleeding after 2h postpartum (178.35 ± 21.12) was significantly higher than that in the control group ml, and the amount of bleeding within 24 hours (267.34 ± 41.12) ml was significantly lower than that of the control group (254.37 ± 28.33) ml, (401.32 ± 51.27) ml, P <0.05. Discussion: The joint use of misoprostol, orgctorepuncture prevent maternal postpartum hemorrhage effect is significant, it is worth to promote and use.